Model Number 97715 |
Device Problems
Migration or Expulsion of Device (1395); Unstable (1667); Charging Problem (2892)
|
Patient Problems
Seroma (2069); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 02/01/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The manufacturer representative (rep) reported that the patient reported they were having difficulty recharging. the rep met with the patient and palpated the pocket site. the rep noticed that the implanted neurostimulator (ins) felt like it was on its side instead of flat to the body. the patient was referred for an x-ray to determine the position of the ins. depending on the position of the ins, the pocket may be revised. no symptoms reported.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information was received from the manufacturer representative (rep) reporting that factors/circumstances that the patient experienced that may have caused the ins to fee like it was on its side was the patient had issues recharging and when they felt over the pocket site with their hand it felt like it was on its side.It was indicated that the x-ray did show that the stimulator had moved some so was not laying flat against their skin.The rep indicated that they believed the battery orientation caused the difficulties charging the ins.It was indicated that the patient has a follow-up appointment on 3/16 with the pain physician to determine if a pocket revision is needed.It was indicated that the patient was still having trouble recharging.
|
|
Event Description
|
The rep stated that a pocket revision was determined to be needed and was currently being scheduled.It was noted that no falls took place, but the physician believed the patient had a seroma as a result of the implant so the battery was able to move freely before scarring into place.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|